SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $444,000 | -23.3% | 3,164 | 0.0% | 0.02% | -21.1% |
| Q2 2019 | $579,000 | +20.4% | 3,164 | +4.6% | 0.02% | +11.8% |
| Q1 2019 | $481,000 | +90.9% | 3,024 | +14.9% | 0.02% | +70.0% |
| Q4 2018 | $252,000 | -36.2% | 2,632 | -6.0% | 0.01% | -23.1% |
| Q3 2018 | $395,000 | +348.9% | 2,800 | +400.0% | 0.01% | +333.3% |
| Q2 2018 | $88,000 | +2100.0% | 560 | +1900.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |